Capital Fund Management (CFM)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,540
Closed -$762K 2010
2025
Q4
$762K Sell
28,540
-48,821
-63% -$1.17M 0.01% 2115
2025
Q3
$1.65M Sell
77,361
-47,763
-38% -$1.13M 0.02% 1869
2025
Q2
$2.7M Sell
125,124
-150,350
-55% -$2.79M 0.03% 1514
2025
Q1
$4.58M Sell
275,474
-385,156
-58% -$7M 0.06% 1052
2024
Q4
$12.1M Sell
660,630
-123,399
-16% -$1.99M 0.12% 670
2024
Q3
$12.1M Sell
784,029
-132,580
-14% -$2.21M 0.13% 647
2024
Q2
$14.9M Buy
916,609
+221,062
+32% +$3.57M 0.17% 519
2024
Q1
$12.9M Buy
695,547
+451,735
+185% +$11.2M 0.16% 622
2023
Q4
$7.63M Buy
243,812
+68,120
+39% +$1.63M 0.1% 915
2023
Q3
$3.66M Sell
175,692
-55,769
-24% -$1.51M 0.05% 1095
2023
Q2
$5.54M Buy
231,461
+70,616
+44% +$1.57M 0.09% 807
2023
Q1
$3.03M Sell
160,845
-79,626
-33% -$1.52M 0.06% 919
2022
Q4
$3.83M Sell
240,471
-22,655
-9% -$354K 0.08% 717
2022
Q3
$4.3M Buy
263,126
+60,474
+30% +$979K 0.11% 595
2022
Q2
$2.86M Buy
202,652
+122,533
+153% +$2.29M 0.08% 701
2022
Q1
$1.94M Buy
80,119
+27,078
+51% +$655K 0.05% 960
2021
Q4
$1.24M Sell
53,041
-8,305
-14% -$167K 0.03% 1208
2021
Q3
$1.02M Buy
61,346
+26,058
+74% +$502K 0.03% 1180
2021
Q2
$861K Buy
+35,288
New +$796K 0.02% 1195
2020
Q4
Sell
-13,550
Closed -$559K 1261
2020
Q3
$559K Sell
13,550
-3,477
-20% -$150K 0.02% 1027
2020
Q2
$825K Buy
+17,027
New +$817K 0.03% 748
2020
Q1
Sell
-8,493
Closed -$363K 1508
2019
Q4
$363K Sell
8,493
-437
-5% -$19K 0.01% 1524
2019
Q3
$321K Buy
+8,930
New +$271K 0.01% 1405

Other funds holding ACAD